Aramark Files 8-K for Regulation FD Disclosure

TL;DR

Aramark filed a standard 8-K for Reg FD disclosure, no new material info.

AI Summary

On January 17, 2025, Aramark filed an 8-K, indicating a Regulation FD Disclosure. The filing does not contain specific financial transactions or material events beyond this disclosure type. The company's principal executive offices are located at 2400 Market Street, Philadelphia, PA.

Why It Matters

This filing serves as a notification to the public regarding regulatory compliance, ensuring transparency in communications. It does not disclose new financial information or strategic changes.

Risk Assessment

Risk Level: low — The filing is a routine disclosure and does not contain information that would typically impact stock price or indicate new risks.

Key Players & Entities

• Aramark (company) — Registrant
• 2400 Market Street, Philadelphia, PA (location) — Principal Executive Offices
• January 17, 2025 (date) — Date of Report

FAQ

Key Financial Figures

• $0.01 — ich Registered Common Stock, par value $0.01 per share ARMK New York Stock Exchange
• $551,538,000 — 025 (the "Redemption Date"), the entire $551,538,000 aggregate principal amount of 2025 Note
• $1,395 million — 030 in an aggregate principal amount of $1,395 million (the "New U.S. Term B-8 Loans"). It is

Filing Documents

• cik0-20250117.htm (8-K) — 27KB
• 0001584509-25-000009.txt ( ) — 149KB
• cik0-20250117.xsd (EX-101.SCH) — 2KB
• cik0-20250117_lab.xml (EX-101.LAB) — 22KB
• cik0-20250117_pre.xml (EX-101.PRE) — 12KB
• cik0-20250117_htm.xml (XML) — 3KB

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure On January 17, 2025, Aramark Services, Inc. (the "Issuer"), an indirect wholly owned subsidiary of Aramark, issued a notice of conditional redemption pursuant to the indenture, dated as of March 22, 2017, as supplemented, among the Issuer, the guarantors party thereto and The Bank of New York Mellon, as trustee, relating to the Issuer's 5.000% Senior Notes due 2025 (the "2025 Notes"), notifying holders that the Issuer has elected to redeem (the "Redemption"), on February 18, 2025 (the "Redemption Date"), the entire $551,538,000 aggregate principal amount of 2025 Notes currently outstanding at a redemption price equal to 100.000% of the aggregate principal amount of such 2025 Notes, plus accrued and unpaid interest to the date of redemption. The Redemption is conditioned upon the receipt by the Issuer of proceeds from the incurrence of new indebtedness in an amount sufficient to pay in full all amounts due in connection with the Redemption. This condition may be waived by the Issuer in its sole discretion. In addition, the date of redemption may, in the Issuer's discretion, be delayed until such time as the foregoing condition is satisfied or waived. In connection with the Redemption, the Issuer has completed a syndication process for new U.S. dollar denominated term loans due June 2030 in an aggregate principal amount of $1,395 million (the "New U.S. Term B-8 Loans"). It is currently anticipated that the New U.S. Term B-8 Loans will be incurred concurrent with the Redemption on the Redemption Date, with remaining proceeds following the Redemption used to refinance existing term loans and pay related fees and expenses. These transactions will be net leverage neutral to Aramark . The information furnished pursuant to Item 7.01 of this Current Report on Form 8-K shall not be considered "filed" under the Securities Exchange Act of 1934, as amended, nor shall it be incorporated by reference into future filings by Aramark under

View Full Filing

View this 8-K filing on SEC EDGAR